Akari Therapeutics Plc (AKTX)

4.59 -0.04 (-0.86%) USD  |  NASDAQ  |  Apr 15, 16:00
4.59 0.00 (0.00%) After-Hours: 20:00
More

Akari Therapeutics Research and Development Expense (Annual) : 2.822M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
DBV Technologies SA 107.12M
Cellectis SA 75.08M
Biodexa Pharmaceuticals Plc 5.026M
Mereo BioPharma Group Plc 17.81M
Bicycle Therapeutics Plc 275.85M